Parallel Advisors, LLC Novo Nordisk A S Transaction History

Parallel Advisors, LLC

$4.34 Billion
Q4 2024

A detailed history of Parallel Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Parallel Advisors, LLC holds 48,119 shares of NVO stock, worth $4.24 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

48,119

Previous 51,387 6.36%

Holding current value

$4.24 Million

Previous $6.12 Million 32.35%

% of portfolio

0.1%

Previous 0.15%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$85.0 - $120.04 $277,780 - $392,290	-3,268 Reduced 6.36%	48,119 $4.14 Million
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $14,764 - $18,032	124 Added 0.24%	51,387 $6.12 Million
Q2 2024 Aug 08, 2024	BUY	$122.71 - $146.91 $6,749 - $8,080	55 Added 0.11%	51,263 $7.32 Million
Q1 2024 May 06, 2024	BUY	$102.11 - $135.92 $900,916 - $1.2 Million	8,823 Added 20.82%	51,208 $6.58 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $137,639 - $165,345	1,568 Added 3.84%	42,385 $4.38 Million
Q3 2023 May 20, 2024	BUY	$90.94 - $199.54 $1.88 Million - $4.12 Million	20,657 Added 102.47%	40,817 $3.71 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $1.88 Million - $4.12 Million	20,657 Added 102.47%	40,817 $3.71 Million
Q2 2023 May 20, 2024	BUY	$155.98 - $172.65 $137,106 - $151,759	879 Added 4.56%	20,160 $3.26 Million
Q2 2023 Aug 04, 2023	BUY	$155.98 - $172.65 $137,106 - $151,759	879 Added 4.56%	20,160 $3.26 Million
Q1 2023 May 20, 2024	SELL	$132.34 - $159.14 $4.23 Million - $5.08 Million	-31,927 Reduced 62.35%	19,281 $3.07 Million
Q1 2023 Apr 25, 2023	BUY	$132.34 - $159.14 $842,211 - $1.01 Million	6,364 Added 49.27%	19,281 $3.07 Million
Q4 2022 Feb 03, 2023	SELL	$102.55 - $135.33 $47,685 - $62,928	-465 Reduced 3.47%	12,917 $1.75 Million
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $24,010 - $29,466	-252 Reduced 1.85%	13,382 $1.33 Million
Q2 2022 Aug 01, 2022	BUY	$103.24 - $121.81 $21,473 - $25,336	208 Added 1.55%	13,634 $1.52 Million
Q1 2022 Apr 28, 2022	BUY	$93.1 - $112.54 $110,323 - $133,359	1,185 Added 9.68%	13,426 $1.51 Million
Q4 2021 Jan 20, 2022	BUY	$95.88 - $117.08 $55,802 - $68,140	582 Added 4.99%	12,241 $1.37 Million
Q3 2021 Nov 02, 2021	SELL	$84.42 - $106.62 $69,308 - $87,535	-821 Reduced 6.58%	11,659 $1.12 Million
Q2 2021 Aug 06, 2021	BUY	$67.66 - $84.76 $55,007 - $68,909	813 Added 6.97%	12,480 $1.05 Million
Q1 2021 Apr 23, 2021	BUY	$67.06 - $75.82 $22,532 - $25,475	336 Added 2.97%	11,667 $787,000
Q4 2020 Feb 02, 2021	BUY	$63.89 - $73.8 $197,356 - $227,968	3,089 Added 37.48%	11,331 $791,000
Q3 2020 Oct 27, 2020	BUY	$63.69 - $70.22 $83,879 - $92,479	1,317 Added 19.02%	8,242 $572,000
Q2 2020 Jul 16, 2020	BUY	$58.54 - $67.94 $27,455 - $31,863	469 Added 7.26%	6,925 $453,000
Q1 2020 Apr 27, 2020	BUY	$49.46 - $64.78 $4,154 - $5,441	84 Added 1.32%	6,456 $388,000
Q4 2019 Jan 30, 2020	BUY	$49.86 - $58.26 $12,764 - $14,914	256 Added 4.19%	6,372 $369,000
Q3 2019 Nov 01, 2019	SELL	$47.54 - $53.43 $9,793 - $11,006	-206 Reduced 3.26%	6,116 $316,000
Q2 2019 Aug 05, 2019	SELL	$46.79 - $52.47 $3,415 - $3,830	-73 Reduced 1.14%	6,322 $323,000
Q1 2019 May 01, 2019	BUY	$46.36 - $52.63 $36,160 - $41,051	780 Added 13.89%	6,395 $335,000
Q4 2018 Feb 05, 2019	BUY	$41.54 - $47.25 $1,329 - $1,512	32 Added 0.57%	5,615 $258,000
Q3 2018 Nov 01, 2018	SELL	$46.76 - $51.24 $1,309 - $1,434	-28 Reduced 0.5%	5,583 $263,000
Q2 2018 Jul 30, 2018	BUY	$44.29 - $50.42 $18,601 - $21,176	420 Added 8.09%	5,611 $258,000
Q1 2018 May 08, 2018	SELL	$48.49 - $58.14 $6,594 - $7,907	-136 Reduced 2.55%	5,191 $256,000
Q4 2017 Feb 13, 2018	BUY	$47.53 - $53.73 $5,561 - $6,286	117 Added 2.25%	5,327 $286,000
Q3 2017 Nov 15, 2017	BUY	$41.15 - $49.22 $214,391 - $256,436	5,210 New	5,210 $259,000
Q3 2017 Nov 14, 2017	SELL	$41.15 - $49.22 $169,044 - $202,195	-4,108 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	4,108	4,108 $174,000

Others Institutions Holding NVO

# of Institutions

1,881

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $199B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Novo Nordisk A S Transaction History